Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cutaneous mechanoreceptors are specialized sensory receptors in the skin that detect mechanical stimuli—including touch, pressure, stretch, and vibration—and convert them into electrical signals for the central nervous system[1][2][3][5][7][9]. Cutaneous mechanoreceptors comprise several receptor types embedded throughout layers of the skin, each responsible for transducing specific mechanical stimuli into neural activity. The principal types are: - **Merkel cell-neurite complexes (Merkel discs):** Slowly adapting, fine touch and form, found in basal epidermis, dense in fingertips and lips. - **Meissner corpuscles (tactile corpuscles):** Rapidly adapting, fine touch, low-frequency vibration, concentrated in glabrous (hairless) skin such as fingertips. - **Ruffini corpuscles (bulbous corpuscles):** Slowly adapting, sense skin stretch and finger position, located in deeper dermis. - **Pacinian corpuscles (lamellar corpuscles):** Rapidly adapting, deep pressure, high-frequency vibration, found deeper in dermis and near bone. - **Hair follicle receptors:** Rapidly adapting mechanoreceptors, detect hair movement. - **Free nerve endings:** Can be mechanosensitive; detect crude touch, tickle, itch—less specialized than corpuscular types[1][2][4][5][7][9]. These receptors differ in their morphology, receptive field size, rate of adaptation (rapid vs. slow), and functional specialization. All are innervated by myelinated Aβ fibers (except for some free nerve endings with Aδ fibers)[1][2][4][5]. **Cutaneous mechanoreceptors are not a single molecule but rather a diverse group of specialized cells and structures**. Therefore, they are not considered a canonical therapeutic target or druggable receptor in the molecular sense (such as "Histamine H1 receptor" or "Sodium channel protein type 1 subunit alpha"). Some molecular determinants—such as ion channels (e.g., Piezo2) and accessory proteins—underlie mechanotransduction within these receptors, but "cutaneous mechanoreceptor" itself does not refer to a drug target[5][8]. Mechanoreceptors contribute to conditions such as sensory neuropathy, neuropathic pain, and may play a role in neurodegenerative processes and altered sensory perception[2][5]. **Summary of conventions:** - "Cutaneous mechanoreceptor" is a scientific term describing a functional class of sensory receptor, **not a single molecule or drug target**. - No standard abbreviation is used. - The entry is considered *incorrect* for a canonical "target" database mapping. **For structured information, select the specific type / molecule (e.g., "Piezo2 mechanosensitive ion channel", "Merkel cell", "Meissner corpuscle") if targeting a druggable entity or molecular intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cutaneous mechanoreceptor.